These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 2451892)
1. [Treatment of primary immunodeficiencies with intravenous gamma globulin]. García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892 [TBL] [Abstract][Full Text] [Related]
2. The long term treatment of childhood hypogammaglobulinaemia in Melbourne with intravenous gammaglobulin, 1972-1985. Roberton DM; Hosking CS Dev Biol Stand; 1987; 67():273-80. PubMed ID: 2440742 [TBL] [Abstract][Full Text] [Related]
3. Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID). Clin Exp Immunol; 1986 Sep; 65(3):683-90. PubMed ID: 2430746 [TBL] [Abstract][Full Text] [Related]
4. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466 [TBL] [Abstract][Full Text] [Related]
5. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin. Frankel SJ; Polmar SH; Grumet FC; Wedner HJ Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990 [TBL] [Abstract][Full Text] [Related]
6. Plasma therapy: an alternative to gamma globulin injections in immunodeficiency. Stiehm ER Birth Defects Orig Artic Ser; 1975; 11(1):343-6. PubMed ID: 807275 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease. Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105 [No Abstract] [Full Text] [Related]
8. Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. Gardulf A; Björvell H; Gustafson R; Hammarström L; Smith CI Immunodeficiency; 1993; 4(1-4):81-4. PubMed ID: 7513227 [No Abstract] [Full Text] [Related]
9. Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-up. Galli E; Barbieri C; Cantani A; Solano A; Longhi MA; Businco L Ann Allergy; 1990 Feb; 64(2 Pt 1):147-50. PubMed ID: 2106278 [TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative investigations of serum IgG subclasses in immunodeficiency diseases. Oxelius VA Clin Exp Immunol; 1979 Apr; 36(1):112-6. PubMed ID: 466857 [TBL] [Abstract][Full Text] [Related]
11. [The use of human gamma globulin in the treatment of common variable immunodeficiency]. de Gracia J; Vendrell M; Guarner L; Vidal R; Miravitlles M; Mayordomo C; Morell F Med Clin (Barc); 1995 Feb; 104(6):201-6. PubMed ID: 7534366 [TBL] [Abstract][Full Text] [Related]
12. [Side effects of administration of gamma globulin preparations in patients with primary agammaglobulinemia]. Litzman J; Wiedermannová D; Lokaj J; Král V Vnitr Lek; 1992 May; 38(5):490-4. PubMed ID: 1380749 [TBL] [Abstract][Full Text] [Related]
13. Long-term plasma infusions in a patient with ataxia-telangiectasia and deficient IGA and IGE. Ammann AJ; Good RA; Bier D; Fudenberg HH Pediatrics; 1969 Nov; 44(5):672-6. PubMed ID: 4192681 [No Abstract] [Full Text] [Related]